Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability
Anu Wallecha(Advaxis (United States)), Yvonne Paterson(University of Pennsylvania), Vafa Shahabi(Pearl River Community College), Zhen-Kun Pan(University of Pennsylvania), Laurence M. Wood(Texas Tech University), Paulo Maciag(AbbVie (United States))
Cited by 44
Related Papers
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
|The Lancet Oncology|2020|401
Improved Survival in ARDS Patients Associated with a Reduction in Pulmonary Capillary Wedge Pressure
|CHEST Journal|1990|296
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
|Blood|2017|271
Elevated Expression of ISG15 in Tumor Cells Interferes with the Ubiquitin/26S Proteasome Pathway
|Cancer Research|2006|194
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
|Frontiers in Cellular and Infection Microbiology|2014|157